<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Navigating Market Challenges: Essential Insights for Moderna Employees Amidst Tech Sector Volatility

image-table

Healthcare Provider Update: Provides health insurance, dental, vision, and mental health benefits, with generous disability and parental leave policies 4. With ACA subsidies set to expire, Modernas robust benefits package offers financial stability and comprehensive care that may outperform marketplace alternatives. Click here to learn more

Q1 2026 brought a striking divergence to technology markets. While the broader S&P 500 finished the quarter with a modest gain of approximately 2.4%, the technology sector experienced what analysts have dubbed the "SaaSpocalypse" - a sharp correction in business software valuations triggered by the rapid advancement of AI agents. Between January and mid-March 2026, an estimated $2 trillion in market capitalization evaporated from the software sector, with many SaaS companies seeing share prices decline 25% to 60%. Meanwhile, AI infrastructure providers and select defensive sectors surged. For employees with significant exposure to technology holdings, this divergence serves as a stark reminder that concentration in any single sector - even one that has driven market returns for years - carries meaningful risk.


What's triggering tech sector volatility? Throughout 2025, businesses across the U.S., like Moderna, navigated a market environment shaped by the Federal Reserve's gradual interest rate reductions and surging AI-driven investment. But in early 2026, the rapid deployment of AI agents began disrupting traditional software business models at a pace that caught many investors off guard. Companies that had built high-growth recurring-revenue software businesses saw their valuations slashed as AI tools threatened to automate entire categories of knowledge work. At the same time, the extraordinary concentration of the S&P 500 in a handful of mega-cap technology names amplified the volatility. The Magnificent Seven - Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta, and Tesla - now account for approximately 35% of the S&P 500 by market capitalization, meaning their performance has an outsized influence on index returns. When sentiment shifted in early 2026, the resulting sector rotation - out of high-growth software and into defensive names, energy, and value stocks - moved quickly.


The downside of domination
Stocks tracked by the S&P Information Technology Sector Index experienced sharp divergence in Q1 2026, with software and SaaS names hit hardest while AI infrastructure names outperformed. Plus, like many benchmark indexes, the S&P 500 is weighted by market capitalization (the value of a company's outstanding shares). This gives the largest companies, most of which are in the tech sector, an outsized role in index performance. As of May 31, the information technology sector now accounts for approximately 31% of the market cap of the S&P 500 - up significantly from years prior - compared with weightings of roughly 13% for financials and 12% for healthcare, the next-largest sectors. Nvidia, Apple, and Microsoft are among the three most-valuable companies in the index, with the full Magnificent Seven (Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta, and Tesla) collectively representing approximately 35% of the entire index. 7

For the past several years, tech stock gains drove the market to new heights, but when their share values began to plunge, they dragged the broader stock indexes down with them. Research shows that the Magnificent Seven were responsible for approximately 42% of the S&P 500's total annual return in 2025 - a level of concentration that makes the broader index highly sensitive to shifts in sentiment toward any of these companies. 8

These well-known technology companies have grown into massive multinational businesses that have a major influence on everyday life. Some dominate their respective business spaces — social media, smartphones, online search and advertising, e-commerce, and cloud computing — enough to spark antitrust investigations and calls for stricter regulations in the United States and abroad. They also have plenty of cash on hand, which means they may be in better shape to withstand an economic slowdown than their smaller competitors. 9

Articles you may find interesting:

Loading...


Takeaways for investors
Spreading investments among the 11 sectors of the S&P 500 is a common way to diversify stock holdings. But over time, a stock portfolio that was once diversified can become overconcentrated in a sector that has outperformed the broader market. Tech-sector stocks delivered strong total returns during 2023 through 2025, with AI-driven names generating outsized gains, so Moderna employees and retirees may want to look closely at the composition of their portfolio and consider rebalancing if they find themselves overexposed to this highly volatile sector. (Rebalancing involves selling some investments in order to buy others. Keep in mind that selling investments in a taxable account could result in a tax liability.)  10

If you feel shell-shocked after the recent market turbulence, we suggest our clients from Moderna try to regain some perspective. Some market analysts view recent price declines as a painful but long overdue repricing of stocks with valuations that had grown excessive, as well as a reality check brought on by waning growth expectations. The forward price-to-earnings (P/E) ratio of companies in the S&P 500 reached approximately 22.5x heading into 2026 - approaching historical highs - before the Q1 2026 correction brought it modestly lower. 11-12

It could be a while before investors can better assess how the economy and corporate profits will ultimately fare against AI-driven structural shifts and sector rotation pressures — and the stock market is no fan of uncertainty. Disappointing economic data and company earnings reports could continue to spark volatility in the coming months. 

It may not be easy to take troubling headlines in stride, but if you have a sufficiently diversified, all-weather investment strategy, sticking to it is often the wisest course of action. If you panic and flee the market during a downturn, you won't be in a position to benefit from upward swings on its better days. And if you continue investing regularly for a long-term goal such as retirement, a down market may be an opportunity to buy more shares at lower prices.

The return and principal value of stocks fluctuate with changes in market conditions. Shares, when sold, may be worth more or less than their original cost. Investments seeking a higher return tend to involve greater risk. Diversification is a method we suggest to our clients from Moderna; it's used to help manage risk, but it's also important that Moderna employees note that it doesn't guarantee a profit or protect against investment loss. The S&P 500 is an unmanaged group of securities that is considered representative of the U.S. stock market in general. The performance of an unmanaged index is not indicative of the performance of any specific investment. Individuals cannot invest directly in an index. Past performance is not a guarantee of future results. Actual results will vary. Dollar-cost averaging does not ensure a profit or prevent a loss. Such plans involve continuous investments in securities regardless of fluctuating prices. Moderna employees and retirees should consider their financial ability to continue making purchases during periods of low and high price levels. However, this can be an effective way for investors to accumulate shares to help meet long-term goals.

1) SIFMA, 2022
2) Yahoo! Finance, 2022
3) The New York Times, May 31, 2022
4, 7, 10-11) S&P Dow Jones Indices, 2022
5) U.S. Bureau of Labor Statistics, 2022
6) Federal Reserve, 2022
8) The Wall Street Journal, May 19, 2022
9) The New York Times, May 20, 2022
12) FactSet, 2022

 

What is the 401(k) plan offered by Moderna?

Moderna offers a 401(k) plan that allows employees to save for retirement by contributing a portion of their salary on a pre-tax or Roth after-tax basis.

How can I enroll in Moderna's 401(k) plan?

Employees can enroll in Moderna's 401(k) plan through the company’s benefits portal during the open enrollment period or within 30 days of their hire date.

Does Moderna offer a company match for the 401(k) contributions?

Yes, Moderna provides a company match for employee contributions to the 401(k) plan, which helps boost retirement savings.

What is the maximum contribution limit for Moderna's 401(k) plan?

For 2023, the maximum contribution limit for Moderna's 401(k) plan is $22,500, with an additional catch-up contribution of $7,500 for employees aged 50 and older.

Can I change my contribution percentage to Moderna's 401(k) plan?

Yes, employees can change their contribution percentage to Moderna's 401(k) plan at any time through the benefits portal.

What investment options are available in Moderna's 401(k) plan?

Moderna's 401(k) plan offers a variety of investment options, including mutual funds, target-date funds, and company stock.

How often can I change my investment choices in Moderna's 401(k) plan?

Employees can change their investment choices in Moderna's 401(k) plan at any time, allowing for flexibility in managing their retirement savings.

Is there a vesting schedule for the company match in Moderna's 401(k) plan?

Yes, Moderna has a vesting schedule for the company match, which typically requires employees to work for a certain number of years before they fully own the matched contributions.

Can I take a loan against my 401(k) with Moderna?

Yes, Moderna allows employees to take loans against their 401(k) balance, subject to specific terms and conditions outlined in the plan document.

What happens to my 401(k) plan if I leave Moderna?

If you leave Moderna, you have several options for your 401(k) plan, including rolling it over to an IRA or a new employer's plan, cashing it out, or leaving it with Moderna.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Moderna offers a comprehensive retirement benefits package, which includes a defined contribution 401(k) plan. The company's 401(k) plan allows employees to make contributions through payroll deductions, with Moderna matching contributions based on employee elections. As of 2023, the contribution limit for Moderna employees participating in the 401(k) plan is $22,500, with an additional catch-up contribution of $7,500 for employees aged 50 and older​ (Mondaq)​ (KPMG). These limits reflect increases compared to the prior year, consistent with IRS guidelines. The plan offers both traditional 401(k) and Roth 401(k) options, allowing for tax-deferred or post-tax contributions, depending on the employee's financial strategy. Moderna also offers employer matching contributions, enhancing retirement savings for participating employees. Moderna’s plan provides various investment options, allowing employees to customize their retirement portfolios based on risk tolerance and retirement goals​ (Mondaq). Moderna uses its own specific acronyms, such as "RSP" (Retirement Savings Plan) for the 401(k) plan and "ModMatch" for its matching contribution feature. Employees become eligible for the 401(k) plan upon hire, and those who work at least 500 hours over three consecutive 12-month periods qualify to make contributions starting January 2024, as part of the SECURE Act amendments​
Moderna announced layoffs in 2024, primarily affecting its manufacturing unit, as part of a resizing strategy linked to its COVID production footprint. The company decided to cut jobs due to reduced demand for its COVID-related products and to optimize manufacturing costs. CEO Stéphane Bancel emphasized the importance of ongoing cost improvements in manufacturing as the company pivots away from focusing solely on COVID vaccines toward a broader pharmaceutical portfolio. Moderna expanded its headcount by 44% in 2023, but these layoffs reflect a necessary adjustment to its business strategy moving forward​ (FiercePharma).
Moderna provides its employees with stock options and Restricted Stock Units (RSUs) as part of their long-term incentive compensation. These programs are designed to align employee interests with shareholder value by granting ownership stakes in Moderna. Employees may receive Non-Qualified Stock Options (NSOs) and RSUs, which vest over time. NSOs give employees the right to buy Moderna stock at a pre-determined price, while RSUs grant shares upon vesting without the need for an initial purchase​ (SEC.gov)​ (Moderna). In 2022, Moderna reported that its stock option grants focused on driving financial and operational goals, including stock price appreciation. The company ensures that the majority of executive compensation is tied to at-risk components like stock options and RSUs. These awards are typically available to executives and employees in key roles​ (SEC.gov)​ (Moderna). The RSU program at Moderna also emphasizes long-term retention and performance, rewarding employees based on their contributions to the company's success. Moderna's stock options and RSU plans in 2023 and 2024 remained focused on aligning long-term incentives with business objectives, including the expansion of its pipeline and manufacturing capacity​ (SEC.gov). Executives and high-performing employees across various departments are eligible for these equity awards, ensuring their incentives are linked to Moderna’s overall performance​ (Moderna).
Health Insurance Options: Moderna provides multiple insurance plans, including health, dental, and vision coverage, ensuring that employees have access to preventive and medical care. These plans also include options for telemedicine and wellness care, reflecting industry trends. Lifestyle Spending Account: This program offers employees an annual allowance they can use towards fitness, nutrition, and other wellness activities, helping them maintain a healthy lifestyle. Personal Enrichment Benefit: This unique benefit provides an annual stipend for personal growth, such as attending language classes or certification programs like yoga instruction. Mental Health Support: Moderna prioritizes mental health with programs that offer support through Employee Assistance Programs (EAP), which include confidential counseling services. Family and Parental Benefits: The company has generous parental leave programs and fertility benefits, which have become standard in their competitive benefits package.
New call-to-action

Additional Articles

Check Out Articles for Moderna employees

Loading...

For more information you can reach the plan administrator for Moderna at , ; or by calling them at .

https://rodgers-associates.com/blog/5-steps-successful-nua-transaction/ https://www.retirementwatch.com/the-net-unrealized-appreciation-nua-tax-strategy https://www.fidelity.com/learning-center/personal-finance/retirement/company-stock https://www.mondaq.com/unitedstates/employee-benefits-compensation/1377676/2023-retirement-plan-year-end-amendments-and-operational-compliancehttps://kpmg.com/us/en/home/insights/2023/11/tnf-notice-2023-75-pension-plans-cost-of-living-adjustments-2024.html https://tax.thomsonreuters.com/blog/irs-announces-2023-retirement-plan-dollar-limits-and-thresholds/ https://en.wikipedia.org/wiki/Moderna_COVID-19_vaccine https://www.irs.gov/retirement-plans/pension-plan-funding-segment-rates https://www.foxrothschild.com/publications/interest-rate-hikes-present-challenge-for-fully-funded-pension-plans https://www.mondaq.com/unitedstates/retirement-superannuation-pensions/1275478/secure-20-new-laws-expand-retirement-plan-eligibility-for-long-term-part-time-employees https://www.sec.gov/Archives/edgar/data/1682852/000130817923000184/lmrna2023_def14a.htm https://www.fiercepharma.com/pharma/moderna-lays-parts-manufacturing-team-after-rightsizing-covid-footprint https://investors.modernatx.com/news/news-details/2023/Moderna-to-Acquire-OriCiro-Genomics/default.aspx https://www.pharmanewsintel.com/news/moderna-to-buy-japanese-firm-oriciro-in-its-first-ever-acquisition https://www.thelayoff.com/t/1rlFrVQz https://www.nerdwallet.com/article/investing/retirement-statistics https://www.fidelity.com/calculators-tools/retirement-calculator/overview https://www.kiplinger.com/ https://www.daypitney.com/ https://www.milliman.com/en/

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Moderna employees